Cough syrups with an ingredient of codeine phosphate have an intoxicating effect on nerves and due to easy availability at chemist shops, it is widely abused.
FDA's Intelligence Branch received information about clandestine distribution of the formulation containing Codeine phosphate narcotic drugs used amongst drug addicts and school children, an FDA official said.
On orders of FDA Commissioner Harshadeep Kamble, the FDA team kept a watch and carried out a test purchase through a fake customer.
Interrogation of Choudhari revealed that the formulations were collected from one Bharat Choudhari at Nalasopara. The FDA team and police raided the godown owned by Bharat Choudhari.
A large stock of cough syrup of about 145 boxes, containing 14,500 bottles, each of 100 ml, were seized of various brands like Rexcof manufactured by Cipla Ltd. Vapi, Reskop manufactured by Promed laboratories Pvt. Ltd Indore, Corex manufactured by Pfizer ltd, Pune, Rancodex manufactured by Smilax healthcare Pvt Ltd Baddi and Marketed by Ranbaxy laboratory Ltd, New Delhi and Conex, Manufactured by Acron Pharmaceuticals, Ahmedabad.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
